Lataz-Co

Timolol maleate and Latanoprost, the active ingredients in Lataz-Co, are a beta‑blocker and a prostaglandin analog presented as ocular drops for topical eye use. They work together to lower intra‑ocular pressure in adults with open‑angle glaucoma or ocular hypertension, helping to prevent optic‑nerve damage and preserve visual function. The combination is indicated for patients requiring dual‑mechanism pressure reduction.

GNH USA supplies Lataz-Co as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established distribution networks across Europe, Asia and the Americas.

Lataz-Co is used in ophthalmology to manage conditions characterized by elevated intra‑ocular pressure.

Open‑angle glaucoma: reduces pressure to prevent progressive optic nerve damage. Ocular hypertension: lowers eye pressure to reduce risk of developing glaucoma. Pseudoexfoliative glaucoma: provides pressure reduction in this secondary form of open‑angle glaucoma.

Common Side Effects: - Eye irritation or burning sensation - Blurred vision shortly after instillation - Redness of the conjunctiva - Itching or mild allergic reaction on the eyelid - Dry eye sensation - Foreign body feeling in the eye

Serious or Rare Side Effects: - Severe allergic reaction with swelling of the eyelid or face - Persistent eye pain or worsening vision loss - Corneal ulcer or keratitis - Systemic bradycardia or hypotension due to beta‑blocker absorption - Acute angle‑closure glaucoma precipitated by prostaglandin effect - Respiratory distress in patients with asthma

Before initiating therapy, evaluate patient medical history and concomitant medications.

Cardiovascular assessment: monitor heart rate and blood pressure in patients with cardiac disease. Respiratory caution: avoid use in patients with severe asthma or chronic obstructive pulmonary disease. Concurrent beta‑blockers: use with caution when systemic beta‑blockers are prescribed. Contact lens wear: advise removal of soft lenses before instillation and for at least 15 minutes after. Allergy screening: check for hypersensitivity to any component of the formulation. Store at room temperature: keep in the original container, protect from light and moisture.

Lataz-Co may interact with other medications affecting intra‑ocular pressure or systemic beta‑adrenergic activity.

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers (e.g., propranolol): risk of additive bradycardia and hypotension. - Inhaled beta‑agonists (e.g., albuterol): may reduce ocular efficacy of timolol. - Monoamine oxidase inhibitors: potential for enhanced ocular hypotensive effect.

Moderate Interactions (Monitor Closely):\n- Other intra‑ocular pressure‑lowering agents (e.g., carbonic anhydrase inhibitors, other prostaglandin analogs): may increase pressure‑lowering effect. - Anticholinergic eye drops: could diminish timolol absorption. - NSAID eye preparations: monitor for additive ocular irritation.